Striatal Delivery of rAAV-hAADC to Rats with Preexisting Immunity to AAV
Open Access
- 1 March 2004
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 9 (3) , 403-409
- https://doi.org/10.1016/j.ymthe.2003.12.005
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapyGene Therapy, 2003
- AAV‐Mediated Gene Transfer for HemophiliaAnnals of the New York Academy of Sciences, 2001
- Adeno‐associated virus seropositivity and HPV‐induced cervical cancer in Spain and ColombiaInternational Journal of Cancer, 2001
- Gene Therapy: Promises and ProblemsAnnual Review of Genomics and Human Genetics, 2001
- Epitope Mapping of Human Anti-Adeno-Associated Virus Type 2 Neutralizing Antibodies: Implications for Gene Therapy and Virus StructureJournal of Virology, 2000
- Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV)Journal of Medical Virology, 1999
- Immune responses to adenovirus and adeno-associated virus in humansGene Therapy, 1999
- Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retinaProceedings of the National Academy of Sciences, 1999
- Transient Immunosuppression Allows Transgene Expression Following Readministration of Adeno-Associated Viral VectorsHuman Gene Therapy, 1998
- Recombinant adeno-associated virus for muscle directed gene therapyNature Medicine, 1997